Clinical Trial Update: Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON) [NA]

View source ↗

Summary

Clinical trial update reporting safety and efficacy results for rAAV2-ND4 in Leber Hereditary Optic Neuropathy; study completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leber Hereditary Optic Neuropathy

Drugs mentioned

• rAAV2-ND4 (rAAV2-ND4)

Snippet

Sponsor: Bin Li | Conditions: Leber Hereditary Optic Neuropathy | NA | Status: COMPLETED | Results posted: 2016-05-02